HIV Clinical Pharmacist Services
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 03/23/2023
Resource updated 06/25/2024
Resource updated 01/08/2024
RWHAP Technical Assistance Provider updated on 02/27/2024
Resource updated 09/19/2023
Resource updated 04/18/2024
Resource updated 06/18/2024
Resource updated 09/19/2023
From the HRSA HIV/AIDS Bureau Listserv, 12/16/22
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
We conducted semi-structured interviews with service providers to investigate current barriers, potential opportunities, estimated costs, and anticipated outcomes of program expansion for food, financial, transportation, and housing support services for RWHAP clients.
Resource (Conference Presentation) updated 09/14/2023
We used a data-driven, mixed method approach to develop a community planning and budget tool to inform resource allocation decision-making to achieve health equity in HIV outcomes among RWHAP clients in the Minneapolis-St. Paul Transitional Grant Area.
Resource (Conference Presentation) updated 09/14/2023
The COVID-19 public health emergency (PHE) exacerbated homelessness and housing instability. NY EMA Planning staff worked collaboratively to address homelessness as a driving force of poorer health outcomes for people living with HIV. This presentation will illustrate community planning processes for addressing housing-related barriers among RWHAP consumers during the PHE.
Resource (Conference Presentation) updated 09/14/2023
Creation on pop-up mobile clinics, created in partnership with an established Syringe Support Program (SSP) and academic organizations, to provide one stop STI/HCV/HIV testing and COVID-19 vaccination for people experiencing substance use/homelessness, who have increased risks for these conditions.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Description of HRSA's Best Practices Compilation (targethiv.org/bestpractices), which allows organizations to submit information about their interventions and to search and identify interventions that may work for them.
Resource (Conference Presentation) updated 09/14/2023
After language-specific outreach on getting a COVID-19 vaccination, project saw a high rate of vaccine uptake in Spanish-speaking patients (81%) compared to English-speaking patients (4%).
Resource (Conference Presentation) updated 09/14/2023
The U.S. opioid epidemic has significant impact on rates of overdose deaths among people with HIV. The aim of the project was to leverage the PDSA methodology to enhance a population-based, health information technology, intervention to facilitate the identification and panel management of high-risk clients with opioid use disorder.
Resource (Conference Presentation) updated 09/14/2023